ManufacturingOct 29, 2024
RemeGen Announces the Acceptance of the Marketing Application of Telitaccept for the Treatment of Myasthenia Gravis in China
YANTAI,China,Oct. 29,2024-- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK,688331.SH),a commercial-stage biotechnology company,recently announced that the marketing applic